4.7 Article

Effects and mechanisms of Chinese herbal medicine on IgA nephropathy

Journal

PHYTOMEDICINE
Volume 117, Issue -, Pages -

Publisher

ELSEVIER GMBH
DOI: 10.1016/j.phymed.2023.154913

Keywords

IgA nephropathy; Chinese herbal medicine; Signaling pathway; Mechanism of action; Clinical efficacy

Ask authors/readers for more resources

This review summarizes the clinical efficacy of Chinese herbal medicines (CHMs) and their active ingredients in the treatment and management of IgAN. The study found that CHMs have antioxidant, anti-inflammatory, anti-fibrosis, and autophagy-regulating effects, and can provide a multitarget treatment for IgAN. CHMs can be considered as a first-choice or alternative therapy for IgAN treatment.
Background: Immunoglobulin A nephropathy (IgAN), is the main cause of end-stage renal disease, that causes serious physical and psychological burden to patients worldwide. Some traditional treatment measures, such as blocking the renin-angiotensin-aldosterone system, controlling blood pressure, and following a low-protein diet, may not achieve satisfactory results. Therefore, more effective and safe therapies for IgAN are urgently needed. Purpose: The aim of this review is to summarize the clinical efficacy of Chinese herbal medicines (CHMs) and their active ingredients in the treatment and management of IgAN based on the results of clinical trials, systematic reviews, and meta-analyses, to fully understand the advantages and perspectives of CHMs in the treatment of IgAN. Study design and methods: For this review, the following electronic databases were consulted: PubMed, ResearchGate, Science Direct, Web of Science, Chinese National Knowledge Infrastructure and Wanfang Data, IgA nephropathy, traditional Chinese medicine, Chinese herbal medicine, herb, mechanism, Metaanalysis, systematic review, RCT and their combinations were the keywords to search the relevant literature. Data were collected from 1990 to 2022. Results: This review found that the active ingredients of CHMs commonly act on multiple signaling pathways in the clinical treatment of IgAN, mainly with antioxidant, anti-inflammatory and anti-fibrosis effects, and regulation of autophagy. Conclusion: Compared with the single-target therapy of modern medicine, CHMs can regulate the corresponding pathways from the aspects of anti-inflammation, anti-oxidation, anti-fibrosis and autophagy to play a multitarget treatment of IgAN through syndrome differentiation and treatment, which has good clinical efficacy and can be used as the first choice or alternative therapy for IgAN treatment. This review provides evidence and research direction for a comprehensive clinical understanding of the protective effect of Chinese herbal medicine on IgAN.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available